Antiphospholipid antibodies positivity as a potential risk factor for restenosis following arteriovenous fistula stenting in hemodialysis patients: a pilot study

Antiphospholipid antibodies positivity as a potential risk factor for restenosis following arteriovenous fistula stenting in hemodialysis patients: a pilot study

BackgroundThe arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis. AVF stenosis is a common complication, often requiring balloon angioplasty. For recurrent stenosis, AVF stenting may be an option. Persistent antiphospholipid antibody (aPL) positivity is frequently observed...

Full description

Saved in:
Bibliographic Details
Main Authors: Maxime Taghavi, Adrien Lengelé, Marc Laureys, Lucas Jacobs, Saleh Kaysi, Frédéric Collart, Anne Demulder, Joëlle Nortier
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Medicine
Subjects:
antiphospholipid antibodies
arteriovenous fistula
stenosis
stent
drug elusion coating
drug-eluted stent
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1497810/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items